Twist Bioscience Creates Custom Whole Exome Target Enrichment Panel for Canine Genomic Research

SOUTH SAN FRANCISCO, Calif. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced today an agreement with the Broad Institute to make available a whole exome target enrichment panel to enable next-generation sequencing...

Click to view original post